|
|
Line 16: |
Line 16: |
|
| |
|
| ===Differentiating different thrombophilias on the basis of symptoms, physical examination, and laboratory findings=== | | ===Differentiating different thrombophilias on the basis of symptoms, physical examination, and laboratory findings=== |
| {|
| |
| |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
| |
| ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
| |
| | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| |
| ! colspan="4" rowspan="2" |Para-clinical findings
| |
| | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| |
| ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
| |
| |-
| |
| | colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
| |
| | colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Physical examination'''
| |
| |-
| |
| ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Lab Findings'''
| |
| ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Imaging'''
| |
| |-
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms of DVT
| |
| ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms of Pulmonary Embolism
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms of Myocardial Infarction
| |
| ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness in extremities
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Edema in extremities
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Warmth in extremities
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |aPTT
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Doppler ultrasound
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Chest CT scan
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Antithrombin III deficiency]]<ref name="pmid19141163">{{cite journal |vauthors=Patnaik MM, Moll S |title=Inherited antithrombin deficiency: a review |journal=Haemophilia |volume=14 |issue=6 |pages=1229–39 |date=November 2008 |pmid=19141163 |doi=10.1111/j.1365-2516.2008.01830.x |url=}}</ref><ref name="Al HadidiWu2017">{{cite journal|last1=Al Hadidi|first1=Samer|last2=Wu|first2=Kristi|last3=Aburahma|first3=Ahmed|last4=Alamarat|first4=Zain|title=Family with clots: antithrombin deficiency|journal=BMJ Case Reports|year=2017|pages=bcr-2017-221556|issn=1757-790X|doi=10.1136/bcr-2017-221556}}</ref><ref name="pmid21772860">{{cite journal |vauthors=Konecny F |title=Inherited trombophilic states and pulmonary embolism |journal=J Res Med Sci |volume=14 |issue=1 |pages=43–56 |date=January 2009 |pmid=21772860 |pmc=3129068 |doi= |url=}}</ref>
| |
|
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | -
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | Normal
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Normal
| |
|
| |
| * Reduces the Increase in [[PTT]] after administration of [[heparin]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Evidence of [[deep vein thrombosis]] ([[DVT]])
| |
| * Should be used for diagnosis and follow up
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Occlusion]] of [[brachiocephalic]] [[vein]]
| |
| * Large [[thrombus]] in [[superior vena cava]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Decreased [[plasma]] [[Antithrombin III|antithrombin]] ([[AT III]]) activity
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Nephrotic syndrome]]
| |
| * Decreased inhibition of [[factor II]] and Xa
| |
| * [[Antithrombin]] is a natural [[anticoagulant]] that is lost in the [[urine]]
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Factor V Leiden mutation]]<ref name="pmid20626623">{{cite journal |vauthors=Mannucci PM, Asselta R, Duga S, Guella I, Spreafico M, Lotta L, Merlini PA, Peyvandi F, Kathiresan S, Ardissino D |title=The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease |journal=J. Thromb. Haemost. |volume=8 |issue=10 |pages=2116–21 |date=October 2010 |pmid=20626623 |doi=10.1111/j.1538-7836.2010.03982.x |url=}}</ref><ref name="pmid27797270">{{cite journal |vauthors=Campello E, Spiezia L, Simioni P |title=Diagnosis and management of factor V Leiden |journal=Expert Rev Hematol |volume=9 |issue=12 |pages=1139–1149 |date=December 2016 |pmid=27797270 |doi=10.1080/17474086.2016.1249364 |url=}}</ref><ref name="pmid15003896">{{cite journal |vauthors=Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV |title=The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis |journal=Haematologica |volume=89 |issue=2 |pages=201–6 |date=February 2004 |pmid=15003896 |doi= |url=}}</ref><ref name="pmid23615845">{{cite journal| author=Dentali F, Pomero F, Borretta V, Gianni M, Squizzato A, Fenoglio L et al.| title=Location of venous thrombosis in patients with FVL or prothrombin G20210A mutations: systematic review and meta-analysis. | journal=Thromb Haemost | year= 2013 | volume= 110 | issue= 1 | pages= 191-4 | pmid=23615845 | doi=10.1160/TH13-02-0163 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23615845 }}</ref><ref name="pmid12421138">{{cite journal |vauthors=Press RD, Bauer KA, Kujovich JL, Heit JA |title=Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders |journal=Arch. Pathol. Lab. Med. |volume=126 |issue=11 |pages=1304–18 |date=November 2002 |pmid=12421138 |doi=10.1043/0003-9985(2002)126<1304:CUOFVL>2.0.CO;2 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" |N/A
| |
| | style="background: #F5F5F5; padding: 5px;" |↑
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Recommended to do weekly
| |
| * [[Proximal]] [[DVT]] is more commonly observed as compared to [[distal]] [[DVT]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Pulmonary embolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * N/A
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Inactivates factor Va and factor VIIIa
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Protein C deficiency]]<ref>{{Cite journal
| |
| | author = [[Bernard Khor]] & [[Elizabeth M. Van Cott]]
| |
| | title = Laboratory tests for protein C deficiency
| |
| | journal = [[American journal of hematology]]
| |
| | volume = 85
| |
| | issue = 6
| |
| | pages = 440–442
| |
| | year = 2010
| |
| | month = June
| |
| | doi = 10.1002/ajh.21679
| |
| | pmid = 20309856
| |
| }}</ref><ref name="pmid11336597">{{cite journal |vauthors=Pescatore SL |title=Clinical management of protein C deficiency |journal=Expert Opin Pharmacother |volume=2 |issue=3 |pages=431–9 |date=March 2001 |pmid=11336597 |doi=10.1517/14656566.2.3.431 |url=}}</ref><ref name=":0">{{Cite journal
| |
| | author = [[Gustavo A. Rodriguez-Leal]], [[Segundo Moran]], [[Roberto Corona-Cedillo]] & [[Rocio Brom-Valladares]]
| |
| | title = Portal vein thrombosis with protein C-S deficiency in a non-cirrhotic patient
| |
| | journal = [[World journal of hepatology]]
| |
| | volume = 6
| |
| | issue = 7
| |
| | pages = 532–537
| |
| | year = 2014
| |
| | month = July
| |
| | doi = 10.4254/wjh.v6.i7.532
| |
| | pmid = 25068006
| |
| }}</ref>
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | -
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | Normal
| |
| | style="background: #F5F5F5; padding: 5px;" |Normal / ↑
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Hypercoagulation]]
| |
| * Recurrent [[venous thromboembolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Venous thromboembolism]]
| |
| * [[Pulmonary embolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Protein C]] functional [[assay]]
| |
| * [[ELISA]] [[assay]]: may produce [[false positive]] result in cross reaction with [[rheumatoid factor]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Factor VIII]] elevation in acute phase
| |
| * Functional [[assay]] should not be performed if patient is on [[warfarin]]
| |
| * [[Purpura fulminans]] ([[skin]] [[necrosis]]) could be a form of presentation
| |
| * Risk of [[thrombotic]] [[skin]] [[necrosis]] following [[warfarin]] administration
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Protein S deficiency]]<ref name=":0" /><ref>{{Cite journal
| |
| | author = [[Kristi J. Smock]], [[Elizabeth A. Plumhoff]], [[Piet Meijer]], [[Peihong Hsu]], [[Nicole D. Zantek]], [[Nahla M. Heikal]] & [[Elizabeth M. Van Cott]]
| |
| | title = Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories
| |
| | journal = [[Thrombosis and haemostasis]]
| |
| | volume = 116
| |
| | issue = 1
| |
| | pages = 50–57
| |
| | year = 2016
| |
| | month = July
| |
| | doi = 10.1160/TH15-12-0918
| |
| | pmid = 27075008
| |
| }}</ref><ref name="pmid21799399">{{cite journal |vauthors=Ji M, Yoon SN, Lee W, Jang S, Park SH, Kim DY, Chun S, Min WK |title=Protein S deficiency with a PROS1 gene mutation in a patient presenting with mesenteric venous thrombosis following total colectomy |journal=Blood Coagul. Fibrinolysis |volume=22 |issue=7 |pages=619–21 |date=October 2011 |pmid=21799399 |doi=10.1097/MBC.0b013e32834a0421 |url=}}</ref>
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | -
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" |Normal
| |
| | style="background: #F5F5F5; padding: 5px;" |Normal / ↑
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Hypercoagulation]]
| |
| * Recurrent [[venous thromboembolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Pulmonary embolism]]
| |
| * [[Thrombosis]] of [[superior mesenteric vein]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Protein S]] free [[antigen]] [[assay]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * When performing the gold standard test, beware of interference from samples positive for [[Factor V]] [[mutation]], [[protein C deficiency]] and oral [[anticoagulants]] ([[rivaroxaban]])
| |
| * Risk of [[thrombotic]] [[skin]] [[necrosis]] following [[warfarin]] administration
| |
| * Suspected in patients with a strong family history of [[VTE]]
| |
| * [[Post phlebitic syndrome]]
| |
|
| |
| * [[Fetal]] loss
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prothrombin gene mutation G20210A|Prothrombin gene mutation]]<ref name="pmid17474891">{{cite journal| author=Cooper PC, Rezende SM| title=An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations. | journal=Int J Lab Hematol | year= 2007 | volume= 29 | issue= 3 | pages= 153-62 | pmid=17474891 | doi=10.1111/j.1751-553X.2007.00892.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17474891 }}</ref><ref name="pmid12421139">{{cite journal| author=McGlennen RC, Key NS| title=Clinical and laboratory management of the prothrombin G20210A mutation. | journal=Arch Pathol Lab Med | year= 2002 | volume= 126 | issue= 11 | pages= 1319-25 | pmid=12421139 | doi=10.1043/0003-9985(2002)126<1319:CALMOT>2.0.CO;2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12421139 }}</ref><ref name="pmid236158452">{{cite journal| author=Dentali F, Pomero F, Borretta V, Gianni M, Squizzato A, Fenoglio L et al.| title=Location of venous thrombosis in patients with FVL or prothrombin G20210A mutations: systematic review and meta-analysis. | journal=Thromb Haemost | year= 2013 | volume= 110 | issue= 1 | pages= 191-4 | pmid=23615845 | doi=10.1160/TH13-02-0163 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23615845 }}</ref>
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | -
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" |↑
| |
| | style="background: #F5F5F5; padding: 5px;" |N/A
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Proximal]] [[DVT]] is more commonly observed as compared to [[distal]] [[DVT]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Pulmonary embolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Detection of [[mutation]] using [[restriction enzyme]] and [[PCR]]
| |
| * [[DNA testing]] for [[prothrombin G20210A mutation]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Mutation]] causes increased production of [[prothrombin]]
| |
| * Increased [[blood]] levels of [[prothrombin]] lead to [[venous]] clots in the [[circulatory system]]
| |
| * [[Hormonal]] [[oral contraceptive pills]] can increase the risk of [[VTE]]
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Disseminated intravascular coagulation|Disseminated intravascular coagulation (DIC)]]<ref name="pmid25535423">{{cite journal |vauthors=Venugopal A |title=Disseminated intravascular coagulation |journal=Indian J Anaesth |volume=58 |issue=5 |pages=603–8 |date=September 2014 |pmid=25535423 |pmc=4260307 |doi=10.4103/0019-5049.144666 |url=}}</ref><ref name="pmid27276832">{{cite journal |vauthors=Makruasi N |title=Treatment of Disseminated Intravascular Coagulation |journal=J Med Assoc Thai |volume=98 Suppl 10 |issue= |pages=S45–51 |date=November 2015 |pmid=27276832 |doi= |url=}}</ref><ref name="pmid29178991">{{cite journal| author=Cui S, Fu Z, Feng Y, Xie X, Ma X, Liu T et al.| title=The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B. | journal=Thromb Res | year= 2018 | volume= 161 | issue= | pages= 7-11 | pmid=29178991 | doi=10.1016/j.thromres.2017.11.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29178991 }}</ref>
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +/-
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" |↑
| |
| | style="background: #F5F5F5; padding: 5px;" |↑
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Portal vein thrombosis]] is observed in patients with coexistent [[hepatitis B]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Pulmonary embolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * N/A
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Elevated [[fibrin degradation products]] ([[D-dimers]])
| |
| * Decreased [[fibrinogen]]
| |
| * Decreased [[factor V]] and VIII
| |
| * Shistocytes (helmet [[cells]]) on [[peripheral blood smear]]
| |
| * [[Portal vein thrombosis]]
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Antiphospholipid antibody syndrome]]<ref name="pmid24319251">{{cite journal |vauthors=Lim W |title=Antiphospholipid syndrome |journal=Hematology Am Soc Hematol Educ Program |volume=2013 |issue= |pages=675–80 |date=2013 |pmid=24319251 |doi=10.1182/asheducation-2013.1.675 |url=}}</ref><ref name="pmid19624461">{{cite journal |vauthors=Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG |title=Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis |journal=J. Thromb. Haemost. |volume=7 |issue=10 |pages=1737–40 |date=October 2009 |pmid=19624461 |doi=10.1111/j.1538-7836.2009.03555.x |url=}}</ref><ref name="pmid243192512">{{cite journal| author=Lim W| title=Antiphospholipid syndrome. | journal=Hematology Am Soc Hematol Educ Program | year= 2013 | volume= 2013 | issue= | pages= 675-80 | pmid=24319251 | doi=10.1182/asheducation-2013.1.675 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24319251 }}</ref><ref name="pmid29791828">{{cite journal| author=Garcia D, Erkan D| title=Diagnosis and Management of the Antiphospholipid Syndrome. | journal=N Engl J Med | year= 2018 | volume= 378 | issue= 21 | pages= 2010-2021 | pmid=29791828 | doi=10.1056/NEJMra1705454 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29791828 }}</ref><ref name="pmid23488294">{{cite journal| author=Kornacki J, Wirstlein P, Skrzypczak J| title=[Assessment of uterine arteries Doppler in the first half of pregnancy in women with thrombophilia]. | journal=Ginekol Pol | year= 2012 | volume= 83 | issue= 12 | pages= 916-21 | pmid=23488294 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23488294 }}</ref>
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +/-
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" | +
| |
| | style="background: #F5F5F5; padding: 5px;" |N/A
| |
| | style="background: #F5F5F5; padding: 5px;" |↑
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Increased impedance of [[flow]] in [[uterine]] [[arteries]] at 12-20 weeks of [[gestation]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Pulmonary embolism]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * [[Antiphospholipid antibody]]
| |
| * [[Anticardiolipin antibody]]
| |
| * [[Lupus anticoagulant]]
| |
| * Anti-β2GPI [[antibody]]
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| * Both, [[arterial]] and [[venous]] [[thrombosis]] can occur
| |
| * History of [[spontaneous abortions]]
| |
| * [[False positive]] [[VDRL]]
| |
| * [[Stroke]] and [[transient ischemic attack]] ([[TIA]]) are most common forms of presentation of [[arterial thrombosis]]
| |
| |}
| |
|
| |
|
| |
|
| |
|
| {| class="wikitable" | | {| class="wikitable" |